Shimmick Corp. SHIM 深 沪
已收盘 08-01 16:00:00 美东时间
1.67
-0.100
-5.65%
华盛通- 最 高1.78
- 今 开1.78
- 成交量 1.40万股
- 最 低 1.58
- 昨 收 1.77
- 总市值 5748.44万
- 52周最高 3.78
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 1.30
- 委 比 -95.26%
- 总股本 3442.18万
- 历史最高 7.99
- 量 比 0.18
- 振 幅 11.30%
- 历史最低 1.30
- 每 手 1
- 风险率 1.90%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shimmick Preferred Bidder on $156 Million in New Infrastructure Contracts Across California
Shimmick Corporation has secured four new contracts totaling approximately $156 million, with $47 million focused on electrical work. These projects highlight client confidence in Shimmick's expertise in complex infrastructure solutions, particularly in water and electrical resilience. The contracts include wastewater infrastructure upgrades in Modesto, power distribution improvements in Huntington Beach, and pump station constructions in Nicolau...
07-31 12:30
Cognition Therapeutics Presents Results From Phase 2 COG1201 SHIMMER Study Of Zervimesine In Dementia With Lewy Bodies At AAIC 2025
- Zervimesine's impact on debilitating DLB behavioral symptoms highlighted in podium presentation -- Plasma p-tau217 levels can identify Alzheimer's patients most likely to benefit from zervimesine treatment -- Plasma
07-29 19:38
Shimmick Awarded $51 Million Contract for Bellota Weir Modifications in Stockton, California
Shimmick Corporation awarded a $51 million contract for the Bellota Weir Modifications project in Stockton, California. The project involves constructing a new inflatable Obermeyer gate weir, a surface water intake with fish screens, a fish ladder with lamprey ramps, and a gravity flow conveyance system. These upgrades aim to improve water reliability, enhance fish habitats, and support ecological restoration in the region. The project aligns wit...
07-22 12:30
Cognition Therapeutics To Present Results From Phase 2 'SHIMMER' Study Of Zervimesine In Dementia With Lewy Bodies During Oral Presentation At AAIC
- Zervimesine-treated participants tested 86% better on behavioral outcomes (NPI 12), 52% on activities of daily living, 91% on cognitive fluctuations, and 62% on motor symptoms as compared to placebo -- Additional
07-16 19:35
12 Industrials Stocks Moving In Tuesday's Intraday Session
Gainers BioNexus Gene Lab (NASDAQ:BGLC) stock moved upwards by 230.9% to $10.1...
07-02 01:05
Jefferies downgrades SHIMAMURA Co (SHAOF) to a Hold
Jefferies analyst Michael Allen downgraded SHIMAMURA Co (SHAOF – Research Repor...
06-28 16:05
Shimmick Announces Launch Of Axia Electric To Expand Specialized Electrical Offerings Across Infrastructure Markets
Shimmick Corporation ("Shimmick" or the "Company") (NASDAQ:SHIM), a national leader in complex infrastructure solutions, is proud to announce the launch of Axia Electric LLC (Axia Electric), a dedicated electrical
06-24 04:06
Shimmick Launches Axia Electric LLC to Expand Specialized Electrical Offerings Across Infrastructure Markets
Shimmick Corporation launches Axia Electric LLC, a dedicated electrical subsidiary, to meet growing demand for specialized electrical and power distribution solutions. With over 20 years of experience, Axia Electric serves low- and medium-voltage markets, focusing on commissioning, O&M, and turnkey solutions across infrastructure sectors. Recent contract awards total $42 million, with $380 million in active electrical projects. Axia's skilled tea...
06-23 20:05
GALILEI CO. LTD. Announces Director Resignation and Appointment
The latest update is out from FUKUSHIMA GALILEI CO., LTD. ( ($JP:6420) ). GALIL...
06-12 08:22
